杰富瑞（Jefferies）因季度业绩令人失望而下调Cryoport评级

2024-08-07 23:53

Jefferies has downgraded Cryoport (NASDAQ:CYRX) to buy from hold to a slowing growth outlook.
The firm revised its price target to $8 from $20 (3% upside based on Aug. 7 close).
Analyst Matthew Stanton noted that he expects the "stock to remain in penalty box as it will take time for management to rebuild credibility around forecasting after cutting guidance mid-year for the third straight year."
He also questions whether the company's MVE Biological Solutions segment, one of its core businesses that provides cryogenic freezer systems, can meet management's growth expectations.
At the same time, Stanton said that while some of Cryoport's other businesses are poised for growth, they are relatively small and will likely not contribute much to drive significant growth for the company.
Despite the downgrade, shares are up ~4% in Wednesday trading.

More on CryoPort